Log In
Print this Print this

Gimatecan (formerly ST1481)

  Manage Alerts
Collapse Summary General Information
Company Sigma-Tau Group
DescriptionOral camptothecin chemotherapy derivative
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer and other FOLR1-positive solid tumors
Regulatory Designation
PartnerLee's Pharmaceutical Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today